Cambridge Heartwear receives $243m tender for HeartSense wearable
The agreement covers the rollout of the ECG device at primary, secondary care, and civil service departments.
Therapy Area
Patients want flexible and involved cardiac care, but cost hurdles remain
Podcast: Developing non-invasive therapies for glioblastoma
Vara nets first CE mark for autonomous AI breast cancer screening tool
Women’s health attracted record equity in 2025 as companies share capital
Novocure’s Optune Gio fails to show benefit at earlier stage
Parkinson’s disease: neuromodulation and the search for disease modification
Roche’s Elecsys NfL test earns CE mark for multiple sclerosis detection
